Published in Antimicrob Agents Chemother on September 01, 2003
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med (1999) 10.06
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis (2000) 7.80
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med (2002) 6.22
The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis (1996) 3.26
Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob Agents Chemother (1991) 3.18
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother (1999) 2.97
Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob Agents Chemother (1991) 2.93
Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. Emerg Infect Dis (2000) 2.63
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob Agents Chemother (2002) 2.48
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Development of daptomycin for gram-positive infections. J Antimicrob Chemother (2000) 2.21
Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry (1988) 2.14
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 2.14
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob Agents Chemother (1999) 2.02
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Comparative In vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob Agents Chemother (2000) 1.84
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. Eur J Clin Microbiol (1987) 1.76
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother (2003) 1.69
Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis (2001) 1.57
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob Agents Chemother (2001) 1.45
Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones. J Antimicrob Chemother (1989) 1.37
Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media. J Antimicrob Chemother (2001) 0.97
Comparative in-vitro activity of four peptide antibiotics against penicillin-resistant Streptococcus pneumoniae isolated from cerebrospinal fluid (CSF). J Antimicrob Chemother (1992) 0.77
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med (1998) 6.03
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88
Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2003) 4.31
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 3.40
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02
Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol (2001) 2.92
Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis (1995) 2.80
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis (1986) 2.77
Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 2.71
Comparative evaluation of the Limulus assay and the direct Gram stain for detection of significant bacteriuria. Am J Clin Pathol (1975) 2.69
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium. Eur J Clin Microbiol Infect Dis (1990) 2.12
Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother (1983) 2.11
Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay. Appl Microbiol (1973) 2.09
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.06
Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 2.03
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother (1997) 1.95
Xenorhabdus luminescens (DNA hybridization group 5) from human clinical specimens. J Clin Microbiol (1989) 1.88
Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med (1984) 1.88
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1990) 1.87
Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol (1994) 1.78
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob Agents Chemother (1981) 1.77
Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study. J Clin Microbiol (1999) 1.76
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. Eur J Clin Microbiol (1987) 1.76
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Identification of coagulase-negative staphylococci with the API STAPH-IDENT system. J Clin Microbiol (1983) 1.70
Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis (2000) 1.69
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis (2000) 1.69
Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol (2004) 1.65
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.59
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med (1983) 1.56
Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci. J Clin Microbiol (1982) 1.54
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis (1992) 1.53
Comparison of automated and rapid manual methods for the same-day identification of Enterobacteriaceae. Am J Clin Pathol (1983) 1.53
Rapid detection of contaminated intravenous fluids using the Limulus in vitro endotoxin assay. Appl Microbiol (1973) 1.52
Simplified bioassay method for measurement of flucytosine or ketoconazole. J Clin Microbiol (1985) 1.52
Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother (2008) 1.51
Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay. Appl Microbiol (1973) 1.51
Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay. J Clin Microbiol (1978) 1.51
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. J Clin Microbiol (1988) 1.44
Comparison of Legionella pneumophila isolates by arbitrarily primed PCR and pulsed-field gel electrophoresis: analysis from seven epidemic investigations. J Clin Microbiol (1995) 1.40
In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 1.40
Microdilution technique for antimicrobial susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 1.37
Evaluation of the automicrobic system gram-positive identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.35
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.34
High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med (1983) 1.33
Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2000) 1.28
Increased rainfall is associated with increased risk for legionellosis. Epidemiol Infect (2006) 1.27
Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med (1998) 1.27
Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (1993) 1.23
Serogroup Y meningococcal disease in Chicago, 1991-1997. JAMA (1999) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Rapid detection of bacterial endotoxins in drinking water and renovated wastewater. Appl Environ Microbiol (1976) 1.20
Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.20
Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol (2000) 1.17
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15
Characterization of Staphylococcus aureus in a pediatric burn unit. Appl Microbiol (1973) 1.14
In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species. Antimicrob Agents Chemother (1997) 1.14
Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae. Diagn Microbiol Infect Dis (1984) 1.13
Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis (1992) 1.12
Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2. J Clin Microbiol (2000) 1.06
Measurement of bound and free endotoxin by the Limulus assay. Proc Soc Exp Biol Med (1974) 1.06
Collaborative evaluation of the Abbott Avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli. J Clin Microbiol (1984) 1.05
Standardized disk-diffusion susceptibility test for Haemophilus influenzae. Am J Clin Pathol (1977) 1.04
Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study. J Clin Microbiol (2000) 1.04
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. J Clin Microbiol (1992) 1.04
Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates. J Clin Microbiol (1998) 1.03
Ketoconazole therapy of murine cryptococcal meningitis. Am Rev Respir Dis (1982) 1.03
Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis (2001) 1.00
Reproducibility of disc susceptibility tests with Haemophilus influenzae. J Antimicrob Chemother (1991) 1.00
Bacteriophages and endotoxin in licensed live-virus vaccines. J Infect Dis (1975) 1.00
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. Clin Infect Dis (2001) 0.99
Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods. J Clin Microbiol (1984) 0.99
Geometry and respiratory displacement of human ribs. J Appl Physiol (1985) (1987) 0.99
Computerization of a hospital clinical microbiology laboratory. Am J Clin Pathol (1978) 0.99
Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med (1995) 0.99
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. J Clin Microbiol (1992) 0.98
Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts. J Clin Microbiol (1998) 0.98
Rapid detection of significant bacteriuria by use of an automated Limulus amoebocyte lysate assay. J Clin Microbiol (1982) 0.98
Rapid identification of group D streptococci with the API 20S system. J Clin Microbiol (1983) 0.98
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis (2000) 0.98
Rapid determination of novobiocin resistance of coagulase-negative staphylococci with the MS-2 system. J Clin Microbiol (1983) 0.97
Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy. Am J Med (1977) 0.95
In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites. Antimicrob Agents Chemother (1996) 0.95